Tag:
Thallion Pharmaceuticals
Latest Headlines
Latest Headlines
Thallion inks $130M licensing deal with LFB
Canada's Thallion Pharmaceuticals has inked a $130 million licensing deal with LFB Technologies covering the further development and commercialization of a new treatment for Shiga toxin-producing E.
Dispute forces Thallion to halt patient enrollment
Engaged in a squabble with an unnamed licensor, Thallion Pharmaceuticals has called a halt to patient enrollment for a mid-stage study of its experimental therapy for metastatic melanoma. Thallion
Thallion considers buyout in strategic review
Canada's Thallion Pharmaceuticals has brought in Desjardins Securities to advise the company as it reviews a takeover offer. In a brief statement, Thallion noted that the strategic review was
Cash-hungry Thallion hunts for development partner
Thallion Pharmaceuticals is hunting for a partner to help with its development of Shigamabs, a therapy for E. coli food borne bacterial infections. The biotech says it will also delay its Phase
